ATE254915T1 - Kombination von acetyldinalin und docetaxel - Google Patents

Kombination von acetyldinalin und docetaxel

Info

Publication number
ATE254915T1
ATE254915T1 AT02254337T AT02254337T ATE254915T1 AT E254915 T1 ATE254915 T1 AT E254915T1 AT 02254337 T AT02254337 T AT 02254337T AT 02254337 T AT02254337 T AT 02254337T AT E254915 T1 ATE254915 T1 AT E254915T1
Authority
AT
Austria
Prior art keywords
docetaxel
combination
acetyldinalin
acetyldinaline
synergistic
Prior art date
Application number
AT02254337T
Other languages
English (en)
Inventor
William Richard Grove
Ronald Lynn Merriman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE254915T1 publication Critical patent/ATE254915T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Insulated Conductors (AREA)
AT02254337T 2001-07-02 2002-07-01 Kombination von acetyldinalin und docetaxel ATE254915T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30241501P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
ATE254915T1 true ATE254915T1 (de) 2003-12-15

Family

ID=23167645

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02254337T ATE254915T1 (de) 2001-07-02 2002-07-01 Kombination von acetyldinalin und docetaxel

Country Status (20)

Country Link
US (1) US20030083366A1 (de)
EP (1) EP1273296B1 (de)
JP (1) JP2003055208A (de)
KR (1) KR20030015829A (de)
CN (1) CN1394601A (de)
AT (1) ATE254915T1 (de)
AU (1) AU5063302A (de)
CA (1) CA2391753A1 (de)
CZ (1) CZ20022216A3 (de)
DE (1) DE60200101T2 (de)
DK (1) DK1273296T3 (de)
ES (1) ES2208626T3 (de)
HK (1) HK1049794A1 (de)
HU (1) HUP0202120A3 (de)
IL (1) IL150396A0 (de)
PL (1) PL354825A1 (de)
PT (1) PT1273296E (de)
SK (1) SK9342002A3 (de)
TR (1) TR200302193T4 (de)
ZA (1) ZA200205216B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050206A1 (es) * 2003-05-26 2005-03-26 Schering Ag Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
EP2404596A1 (de) * 2006-03-23 2012-01-11 TMRC Co., Ltd. Kit zur Krebsbehandlung und pharmazeutische Zusammensetzung zur Krebsbehandlung
EP2178531A4 (de) * 2007-07-02 2012-01-11 Yu Ming Verfahren, zusammensetzung, ziele für kombinationskrebstherapien
WO2012003413A1 (en) * 2010-06-30 2012-01-05 The Broad Institute, Inc. Novel solid forms of tacedinaline
US8691875B2 (en) 2011-07-01 2014-04-08 Broad Institute, Inc. Solid forms of tacedinaline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
AU6878198A (en) * 1997-04-24 1998-11-13 Warner-Lambert Company Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
HUP0103640A3 (en) * 1998-09-25 2003-01-28 Warner Lambert Co Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
EA200100687A1 (ru) * 1998-12-22 2001-12-24 Варнер Ламберт Компани Комбинированная химиотерапия
GB9904386D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
WO2001034131A2 (en) * 1999-11-10 2001-05-17 Warner-Lambert Company Combination chemotherapy

Also Published As

Publication number Publication date
EP1273296A2 (de) 2003-01-08
US20030083366A1 (en) 2003-05-01
DE60200101T2 (de) 2004-08-26
JP2003055208A (ja) 2003-02-26
ES2208626T3 (es) 2004-06-16
IL150396A0 (en) 2002-12-01
ZA200205216B (en) 2004-02-10
DE60200101D1 (de) 2004-01-08
AU5063302A (en) 2003-01-09
TR200302193T4 (tr) 2004-02-23
DK1273296T3 (da) 2004-03-01
CZ20022216A3 (cs) 2003-05-14
HUP0202120A2 (hu) 2003-01-28
KR20030015829A (ko) 2003-02-25
EP1273296B1 (de) 2003-11-26
HUP0202120A3 (en) 2005-01-28
SK9342002A3 (en) 2003-07-01
EP1273296A3 (de) 2003-01-22
HK1049794A1 (zh) 2003-05-30
HU0202120D0 (de) 2002-09-28
CA2391753A1 (en) 2003-01-02
PT1273296E (pt) 2004-03-31
CN1394601A (zh) 2003-02-05
PL354825A1 (en) 2003-01-13

Similar Documents

Publication Publication Date Title
ATE208382T1 (de) Konjugate von cis-docosahexaensäure und paclitaxel
ATE196844T1 (de) Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
CY1109650T1 (el) Χρηση νευρικων νηματικων πρωτεϊνων για την αντιμετωπιση νεοπλασιων
CY1108563T1 (el) Μεθοδοι και υλικα για τη θεραπεια της ανεπαρκειας (ελλειψης) τεστοστερονης στους ανδρες
TW200501960A (en) Synergistic kits and compositions for treating cancer
ATE414514T1 (de) Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
CY1105892T1 (el) Θepαπεια του ξανθωματος με παραγωγα αζετιδινονης ως αναστολεις απορροφησης στepολης
CY1107439T1 (el) Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα
BR0202519B1 (pt) métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira.
NO20023833D0 (no) Modifiserte cytokiner for anvendelse i cancerterapi
BR0201862A (pt) Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos
ATE381327T1 (de) Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
DE50205814D1 (de) Verwendung von mittelkettigen Triglyceriden zur Prävention und Therapie von Adipositas
DE60200101D1 (de) Kombination von acetyldinalin und docetaxel
UY26431A1 (es) Quimioterapia de combinación
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
ATE415165T1 (de) Kombinierte tumortherapie auf der basis von distamycin-acryloyl derivate und antimetabolische mitteln
DE60303517D1 (de) 100% öl-oberflächenbehandlungszusammensetzung und damit behandelte faseriges garn
EP1646385A4 (de) Verwendung von benzothiopenen zur behandlung und prävention von prostatakrebs
ATE471151T1 (de) Mittel zur prävention und heilung von pathologischen zuständen in verbindung mit endorphin-mangel im organismus
DOP2000000092A (es) Quimioterapia de combinación
ECSP003755A (es) Quimioterapia de combinacion
CY1115806T1 (el) Παραγωγα του κυκλικου eστερα uk-2a χρησιμα στην προληψη ή την αντιμετωπιση μυκητολογικων ασθενειων
UA51054A (uk) Спосіб лікування післяінсультних порушень і пристрій для його реалізації

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1273296

Country of ref document: EP

REN Ceased due to non-payment of the annual fee